Magainin Pharmaceuticals Inc. said it expects to raise about $15.4 million through a private placement to fund clinical trials, research and development, and other projects.
The company, which develops antiinfective and anticancer drugs based on compounds isolated from animals, said it made a private placement of 1.1 million shares at a price of $14 a share.
The private placement is conditioned on the filing of a registration statement, and was arranged by Hambrecht & Quist Inc. and S.G. Warburg & Co.
